Tissue Regenix Group (LSE:TRX) COGS-to-Revenue : 0.54 (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Tissue Regenix Group COGS-to-Revenue?

Tissue Regenix Group's Cost of Goods Sold for the six months ended in Dec. 2023 was £6.54 Mil. Its Revenue for the six months ended in Dec. 2023 was £12.16 Mil.

Tissue Regenix Group's COGS to Revenue for the six months ended in Dec. 2023 was 0.54.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Tissue Regenix Group's Gross Margin % for the six months ended in Dec. 2023 was 46.23%.

Tissue Regenix Group COGS-to-Revenue Historical Data

The historical data trend for Tissue Regenix Group's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tissue Regenix Group COGS-to-Revenue Chart

Tissue Regenix Group Annual Data

Trend

Jan14

Jan15

Jan16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.54

0.57

0.54

0.52

Tissue Regenix Group Semi-Annual Data
	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.60	0.54	0.54	0.51	0.54

Tissue Regenix Group COGS-to-Revenue Calculation

Tissue Regenix Group's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	12.207	/	23.299
	=	0.52

Tissue Regenix Group's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	6.54	/	12.162
	=	0.54

Tissue Regenix Group (LSE:TRX) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Tissue Regenix Group's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	6.54 / 12.162
	=	46.23 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Tissue Regenix Group COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Tissue Regenix Group's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Tissue Regenix Group (LSE:TRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tissue Regenix Group PLC (LSE:TRX) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

LSW:Germany

Address

Lotherton Way, Unit 3, Phoenix Court, Garforth, GBR, LS25 2GY

Website

https://www.tissueregenix.com

Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.